American Society for Microbiology, Microbiology Spectrum, 2023
DOI: 10.1128/spectrum.00333-23
Full text: Download
MAbs are key therapeutic options for COVID-19 prophylaxis and treatment in immunosuppressed and vulnerable populations. Due to the emergence of SARS-CoV-2 variants, including Omicron, it is vital to ensure that neutralization is maintained for MAb-based interventions.